Skip to main content

Locally Advanced and/or Metastatic Solid Tumors GCT1184-01

Status: Open to Enrollment
Email us to enroll

Study details

View study details on clinicaltrials.gov.

Locations

  • Santa Barbara

Clinical trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Phase 1/2 Study of Rina-S in Patients With Locally Advanced and/or Metastatic Solid Tumors

Ryan F Kendle, M.D.
Ryan F Kendle, M.D.
Principal investigator
View profile

Email us to enroll

Related clinical trials

View all clinical trials
  • A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation KRYSTAL-1

    Status: Open to Enrollment

  • Phase 1/2 Study of Rina-S in Patients With Locally Advanced and/or Metastatic Solid Tumors

    Status: Open to Enrollment

  • Targeted Agent and Profiling Utilization Registry (TAPUR) Study

    Status: Open to Enrollment

  • A Randomized, Blinded, Placebo-controlled Trial of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Patients With Cancer Undergoing Chemotherapy

    Status: Open to Enrollment

  • FRAmework-01: A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) Versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan Plus Bevacizumab Versus Platinum-Based Chemotherapy Plus Bevacizumab in Platinum-Sensitive Ovarian Cancer.

    Status: Open to Enrollment

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?